Mayne Pharma Group Ltd - ESG Rating & Company Profile powered by AI
The Disclosure score includes 17 United Nations SDGs including: 'No Poverty', 'Climate Action' and 'Peace, Justice & Strong Institutions'. Complete ESG assessment of Mayne Pharma Group Ltd can be reached by logging in. The dashboard contains a questions and answers table on Mayne Pharma Group Ltd.
Mayne Pharma Group Ltd in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 3.3; made up of an environmental score of 2.0, social score of 4.8 and governance score of 3.2.
3.3
Low ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Caladrius Biosciences Inc | 8.0 | High |
| 1 | Can Fite Biopharma Ltd | 8.0 | High |
| ... | ... | ... | |
| 1234 | Quanterix Corp | 3.4 | Medium |
| 1234 | X4 Pharmaceuticals Inc | 3.4 | Medium |
| 1253 | Mayne Pharma Group Ltd | 3.3 | Medium |
| 1253 | Calithera Biosciences Inc | 3.3 | Medium |
| 1253 | Cara Therapeutics Inc | 3.3 | Medium |
| ... | ... | ... | |
| 1970 | Zyden Gentec Ltd | 0.0 | Low |
| 1970 | iNtRON Biotechnology Inc | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does Mayne Pharma Group Ltd have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Mayne Pharma Group Ltd disclose current and historical energy intensity?
Sign up for free to unlockDoes Mayne Pharma Group Ltd report the average age of the workforce?
Sign up for free to unlockDoes Mayne Pharma Group Ltd reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Mayne Pharma Group Ltd disclose its ethnicity pay gap?
Sign up for free to unlockDoes Mayne Pharma Group Ltd disclose cybersecurity risks?
Sign up for free to unlockDoes Mayne Pharma Group Ltd offer flexible work?
Sign up for free to unlockDoes Mayne Pharma Group Ltd have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Mayne Pharma Group Ltd disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Mayne Pharma Group Ltd conduct supply chain audits?
Sign up for free to unlockDoes Mayne Pharma Group Ltd disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Mayne Pharma Group Ltd conduct 360 degree staff reviews?
Sign up for free to unlockDoes Mayne Pharma Group Ltd disclose the individual responsible for D&I?
Sign up for free to unlockDoes Mayne Pharma Group Ltd disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Mayne Pharma Group Ltd disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Mayne Pharma Group Ltd disclose water use targets?
Sign up for free to unlockDoes Mayne Pharma Group Ltd have careers partnerships with academic institutions?
Sign up for free to unlockDid Mayne Pharma Group Ltd have a product recall in the last two years?
Sign up for free to unlockDoes Mayne Pharma Group Ltd disclose incidents of discrimination?
Sign up for free to unlockDoes Mayne Pharma Group Ltd allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Mayne Pharma Group Ltd issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Mayne Pharma Group Ltd disclose parental leave metrics?
Sign up for free to unlockDoes Mayne Pharma Group Ltd disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Mayne Pharma Group Ltd disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Mayne Pharma Group Ltd disclose the pay ratio of women to men?
Sign up for free to unlockDoes Mayne Pharma Group Ltd support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Mayne Pharma Group Ltd disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Mayne Pharma Group Ltd reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Mayne Pharma Group Ltd involved in embryonic stem cell research?
Sign up for free to unlockDoes Mayne Pharma Group Ltd disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Mayne Pharma Group Ltd disclose its waste policy?
Sign up for free to unlockDoes Mayne Pharma Group Ltd report according to TCFD requirements?
Sign up for free to unlockDoes Mayne Pharma Group Ltd disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Mayne Pharma Group Ltd disclose energy use targets?
Sign up for free to unlockDoes Mayne Pharma Group Ltd disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Mayne Pharma Group Ltd have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Mayne Pharma Group Ltd
These potential risks are based on the size, segment and geographies of the company.
Mayne Pharma Group Limited, a specialty pharmaceutical company, manufactures and sells branded and generic pharmaceutical products in Australia, New Zealand, the United States, Canada, Europe and Asia. The company operates through four segments: Metrics Contract Services, International, Branded Products, and Portfolio Products. It provides oral drug delivery systems; and contract pharmaceutical development, manufacturing, and analytical services to third-party customers, as well as distributes specialty pharmaceutical products in the dermatology, women's health, and infectious disease therapeutic areas. The company was formerly known as Halcygen Pharmaceuticals Limited and changed its name to Mayne Pharma Group Limited in November 2010. Mayne Pharma Group Limited was incorporated in 2005 and is based in Salisbury South, Australia.